Phase II trial of the c-Met inhibitor tepotinib in advanced lung adenocarcinoma with MET exon 14 skipping mutations after failure of prior therapy Meeting Abstract
| Authors: | Paik, P.; Stammberger, U.; Bruns, R.; Overton, L. |
| Abstract Title: | Phase II trial of the c-Met inhibitor tepotinib in advanced lung adenocarcinoma with MET exon 14 skipping mutations after failure of prior therapy |
| Meeting Title: | IASLC 17th World Conference on Lung Cancer |
| Keywords: | lung adenocarcinoma; c-met; tepotinib; exon 14 |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 12 |
| Issue: | 1 Suppl. |
| Meeting Dates: | 2016 Dec 4-7 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2017-01-01 |
| Start Page: | S1230 |
| Language: | English |
| ACCESSION: | WOS:000413055802543 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2016.11.1733 |
| Notes: | Meeting Abstract: P3.02b-066 -- Source: Wos |
